L A Lumley1, C L Robison, B S Slusher, K Wozniak, M Dawood, J L Meyerhoff. 1. Department of Neurochemistry and Neuroendocrinology, Division of Neurosciences, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910, USA. lucille.lumley@na.amedd.army.mil
Abstract
RATIONALE: Long-term individual housing increases aggressive behavior in mice, a condition termed isolation-induced aggression; this aggressiveness is reduced by some antidepressants and anxiolytics. NMDA antagonists also inhibit isolation-induced aggression in mice. The enzyme N-acetylated-alpha-linked acidic dipeptidase (NAALADase) hydrolyzes the neurotransmitter N-acetylaspartylglutamate (NAAG) to form glutamate and N-acetylaspartate; NAAG acts as a partial NMDA agonist as well as a full agonist at the presynaptic metabotropic glutamate receptor 3 (mGluR3), where it acts to reduce glutamate release. OBJECTIVE: We postulated that NAALADase inhibition would reduce isolation-induced aggression in mice. METHODS: We tested whether acute exposure to the NAALADase inhibitor 2-[[hydroxy[2,3,4,5,6-pentafluorophenyl)methyl]phosphinyl]methyl] pentanedioic acid (GPI-5232), administered 30 min prior to a social interaction test, would inhibit aggressive behavior in SJL mice that had been individually housed long term. RESULTS: Administration of GPI-5232 (30 mg/kg, IP) inhibited initiation of aggressive behavior, indicated by greater latencies to display tail-rattling, attack and biting, and by fewer mice initiating aggressive behavior, compared to mice that received vehicle. In addition, GPI-5232 treated mice had fewer tail-rattling responses to a non-aggressive conspecific. CONCLUSIONS: The effectiveness of GPI-5232 in this animal model suggests that NAALADase inhibition may be a novel therapeutic approach to reduce or inhibit heightened aggressiveness, and possibly to treat aggressive behavior associated with psychiatric disorders.
RATIONALE: Long-term individual housing increases aggressive behavior in mice, a condition termed isolation-induced aggression; this aggressiveness is reduced by some antidepressants and anxiolytics. NMDA antagonists also inhibit isolation-induced aggression in mice. The enzyme N-acetylated-alpha-linked acidic dipeptidase (NAALADase) hydrolyzes the neurotransmitter N-acetylaspartylglutamate (NAAG) to form glutamate and N-acetylaspartate; NAAG acts as a partial NMDA agonist as well as a full agonist at the presynaptic metabotropic glutamate receptor 3 (mGluR3), where it acts to reduce glutamate release. OBJECTIVE: We postulated that NAALADase inhibition would reduce isolation-induced aggression in mice. METHODS: We tested whether acute exposure to the NAALADase inhibitor 2-[[hydroxy[2,3,4,5,6-pentafluorophenyl)methyl]phosphinyl]methyl] pentanedioic acid (GPI-5232), administered 30 min prior to a social interaction test, would inhibit aggressive behavior in SJL mice that had been individually housed long term. RESULTS: Administration of GPI-5232 (30 mg/kg, IP) inhibited initiation of aggressive behavior, indicated by greater latencies to display tail-rattling, attack and biting, and by fewer mice initiating aggressive behavior, compared to mice that received vehicle. In addition, GPI-5232 treated mice had fewer tail-rattling responses to a non-aggressive conspecific. CONCLUSIONS: The effectiveness of GPI-5232 in this animal model suggests that NAALADase inhibition may be a novel therapeutic approach to reduce or inhibit heightened aggressiveness, and possibly to treat aggressive behavior associated with psychiatric disorders.
Authors: J A Monn; M J Valli; S M Massey; R A Wright; C R Salhoff; B G Johnson; T Howe; C A Alt; G A Rhodes; R L Robey; K R Griffey; J P Tizzano; M J Kallman; D R Helton; D D Schoepp Journal: J Med Chem Date: 1997-02-14 Impact factor: 7.446
Authors: J H Krystal; D C D'Souza; I L Petrakis; A Belger; R M Berman; D S Charney; W Abi-Saab; S Madonick Journal: Harv Rev Psychiatry Date: 1999 Sep-Oct Impact factor: 3.732
Authors: Cristina Paula do Nascimento; Gabriella Xavier Maretto; Graziany Leite Moreira Marques; Luciana Mesquita Passamani; Ana Paula Abdala; Luiz Carlos Schenberg; Vanessa Beijamini; Karla Nívea Sampaio Journal: Neurotox Res Date: 2017-05-24 Impact factor: 3.911
Authors: Emily L Newman; Adam Chu; Brittany Bahamón; Aki Takahashi; Joseph F Debold; Klaus A Miczek Journal: Psychopharmacology (Berl) Date: 2012-05-16 Impact factor: 4.530
Authors: Jaemin Kim; Falina J Williams; Dayna L Dreger; Jocelyn Plassais; Brian W Davis; Heidi G Parker; Elaine A Ostrander Journal: Proc Natl Acad Sci U S A Date: 2018-07-03 Impact factor: 11.205
Authors: Jessica M Jones; William Foster; Colin R Twomey; Justin Burdge; Osama M Ahmed; Talmo D Pereira; Jessica A Wojick; Gregory Corder; Joshua B Plotkin; Ishmail Abdus-Saboor Journal: Elife Date: 2020-08-06 Impact factor: 8.140